Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hi-Tech rides Mag-Ox growth

This article was originally published in The Tan Sheet

Executive Summary

The recently acquired line of magnesium supplements helps Hi-Tech Pharmacal's Health Care Products division increase sales 17.4 percent to $2.7 million in its fiscal 2010 fourth quarter and 11.9 percent to $11.3 million in the full year ended April 30. Annual sales of Mag-Ox products reached $3.4 million prior to Hi-Tech's March acquisition. The firm plans to increase distribution and extend the brand in the new fiscal year, CEO David Seltzer said July 13 (1"The Tan Sheet" March 8, 2010, In Brief). Amityville, N.Y.-based Hi-Tech, which markets to the diabetic health segment, also attributed OTC growth to increased sales of its Diabetic Tussin and Multi-betic products. The company reported overall net sales of $163.7 million - up 50.7 percent - and net income of $31.1 million - up 217 percent - for fiscal 2010

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104311

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel